Clinical Trial Update: Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates whether dark adaptation can serve as an early indicator of response to statin therapy in intermediate age-related macul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Statin therapy (statin)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Age-related Macular Degeneration | Phase 2 | Status: RECRUITING